PPARGC1A and cardiomyopathy: We further validated the intergenerational lipotoxic cardiomyopathy model by genetically reducing PGC-1 expression in the parents (PGC-1xp heterozygotes), which causes similar cardiac lipotoxicity as HFD exposure16.